LINC00945 and central nervous system cancer: To further explore the expression mechanism of LINC00945 in glioma, we selected five glioma patient-derived GSCs to profile the landscape of active enhancers, based on the fact that the rank ordering of SE-LINC00945 in GSCs ChIP-seq data of these five patients was in the top 5 of 43 glioma patients (Fig. 7A).